Cabaletta Bio, Inc. ( CABA) - Stock Earnings

CABA Upcoming earnings

Estimated EPS and revenue columns are available to paid members.

Date EPS (actual / est.) Revenue low (est.) Revenue (actual / est.) Revenue high (est.)
Nov. 9, 2026, midnight — / — — — / — —

CABA Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -41.9 million USD — USD
2026Q1 -43.5 million USD — USD
2026Q2 -51.0 million USD — USD
2026Q4 Est. — —
2027Q1 Est. — —
2027Q2 Est. — —

CABA Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -67.7 million USD — USD
2024 -115.9 million USD — USD
2025 -167.9 million USD — USD
2026 Est. — —

CABA

Price: $1.41

52 week price:
1.41
4.23

Earnings Per Share: -1.47 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 489500

Market Capitalization: 326.1 million

Links: